Risk factors for early replacement of cardiovascular implantable electronic devices.
暂无分享,去创建一个
Y. Aizawa | K. Fukuda | S. Kohsaka | Y. Katsumata | N. Nishiyama | S. Takatsuki | Takehiro Kimura | Y. Tanimoto | Akira Kunitomi | T. Nishiyama | K. Nakajima | S. Kashimura | Yoshinori Katsumata | Kazuaki Nakajima
[1] Konstantinos C. Siontis,et al. Comparison of the longevity of implantable cardioverter-defibrillator devices by different manufacturers. , 2014, International journal of cardiology.
[2] Samir Saba,et al. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators. , 2014, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[3] SumChe Man,et al. Implantable cardioverter-defibrillator longevity under clinical circumstances: an analysis according to device type, generation, and manufacturer. , 2012, Heart rhythm.
[4] P. Rakovec,et al. Factors Influencing Pacemaker Generator Longevity: Results from the Complete Automatic Pacing Threshold Utilization Recorded in the CAPTURE Trial , 2010, Pacing and clinical electrophysiology : PACE.
[5] Jeroen J. Bax,et al. Recurrent Implantable Cardioverter‐Defibrillator Replacement Is Associated with an Increasing Risk of Pocket‐Related Complications , 2010, Pacing and clinical electrophysiology : PACE.
[6] J. Ornato,et al. ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. , 2008, Heart rhythm.
[7] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Circulation.
[8] Harlan M Krumholz,et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemaker , 2008, Journal of the American College of Cardiology.
[9] D. Cohen,et al. The frequency and incremental cost of major complications among medicare beneficiaries receiving implantable cardioverter-defibrillators. , 2006, Journal of the American College of Cardiology.
[10] Douglas K Owens,et al. Cost-effectiveness of implantable cardioverter-defibrillators. , 2005, The New England journal of medicine.
[11] R. Hauser,et al. The growing mismatch between patient longevity and the service life of implantable cardioverter-defibrillators. , 2005, Journal of the American College of Cardiology.